- Report
- April 2023
- 350 Pages
Global
From €2326EUR$2,600USD£2,045GBP
€2907EUR$3,250USD£2,556GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2326EUR$2,600USD£2,045GBP
€2907EUR$3,250USD£2,556GBP
- Report
- October 2022
- 100 Pages
Global
From €1789EUR$2,000USD£1,573GBP
€2237EUR$2,500USD£1,966GBP
- Report
- September 2022
- 288 Pages
Global
From €6799EUR$7,600USD£5,978GBP
€8499EUR$9,500USD£7,472GBP
- Report
- September 2022
- 239 Pages
Global
From €5368EUR$6,000USD£4,719GBP
€6710EUR$7,500USD£5,899GBP
- Report
- January 2022
- 60 Pages
Global
From €2827EUR$3,160USD£2,485GBP
€3534EUR$3,950USD£3,107GBP
- Report
- April 2020
- 80 Pages
Global
From €2827EUR$3,160USD£2,485GBP
€3534EUR$3,950USD£3,107GBP
- Report
- July 2024
- 110 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- July 2024
- 120 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- February 2024
- 120 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 110 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- August 2022
- 120 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- July 2024
- 258 Pages
Global
From €4428EUR$4,950USD£3,893GBP
- Report
- June 2022
- 207 Pages
Global
From €2348EUR$2,625USD£2,065GBP
€4697EUR$5,250USD£4,129GBP
- Report
- June 2021
Global
From €3578EUR$4,000USD£3,146GBP
- Report
- February 2024
- 70 Pages
Europe
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 111 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- October 2022
- 113 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- May 2023
- 294 Pages
Global
From €4473EUR$5,000USD£3,933GBP
- Report
- February 2025
- 85 Pages
India
From €3131EUR$3,500USD£2,753GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more